Literature DB >> 1712556

Molecular analysis of primitive hematopoietic cell proliferation control mechanisms.

C J Eaves1, J D Cashman, H J Sutherland, T Otsuka, R K Humphries, D E Hogge, P L Lansdorp, A C Eaves.   

Abstract

Cells at two distinct early stages in the development of mature human blood cells from primitive totipotent hematopoietic stem cells can now be defined and quantitated by separate in vitro assays. Current evidence suggests that most, if not all, colony-forming cells--that is, cells that give rise to colonies of mature progeny within one to three weeks in semisolid culture systems, represent an intermediate stage of hematopoietic progenitor. These cells are not self-sustaining; if they are used to initiate hematopoiesis on competent marrow stromal layers, they rapidly disappear as they differentiate or die. However, clonogenic cells can be generated in such cultures from another cell type over a period of four to eight weeks. We have, therefore, assigned the term long-term culture initiating cell (LTC-IC) to this latter type of clonogenic precursor cell. The production and differentiation of cells in both of these compartments in LTC are dependent on, and regulated by, nonhematopoietic "stromal" cells that form a heterogeneous adherent layer in which close-range interactions with hematopoietic cells take place. The use of separate endpoints to monitor the maintenance, differentiation, and reversible activation or arrest of cycling of these cells has recently revealed different molecular mechanisms regulating their respective functions. However, an important common feature appears to be the relative local concentration of positive and negative regulators to which the target hematopoietic cell is exposed. Both gene expression and growth factor release measurements as well as results obtained using genetically engineered stroma and repeated soluble growth factor addition implicate G-CSF as an endogenous positive regulator of primitive hematopoietic cells. Similarly, gene expression, factor production, factor addition, and neutralizing antibody experiments implicate TGF-beta as an endogenous inhibitor of primitive hematopoietic cells.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1712556     DOI: 10.1111/j.1749-6632.1991.tb17260.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  12 in total

1.  Aggregation of human mesenchymal stromal cells (MSCs) into 3D spheroids enhances their antiinflammatory properties.

Authors:  Thomas J Bartosh; Joni H Ylöstalo; Arezoo Mohammadipoor; Nikolay Bazhanov; Katie Coble; Kent Claypool; Ryang Hwa Lee; Hosoon Choi; Darwin J Prockop
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-19       Impact factor: 11.205

Review 2.  Repair of tissues by adult stem/progenitor cells (MSCs): controversies, myths, and changing paradigms.

Authors:  Darwin J Prockop
Journal:  Mol Ther       Date:  2009-03-31       Impact factor: 11.454

3.  Further proof for an unpopular concept: a single cell from bone marrow can serve as a stem cell for both hematopoiesis and osteogenesis.

Authors:  Darwin J Prockop
Journal:  Mol Ther       Date:  2013-06       Impact factor: 11.454

4.  Rapid decline of chronic myeloid leukemic cells in long-term culture due to a defect at the leukemic stem cell level.

Authors:  C Udomsakdi; C J Eaves; B Swolin; D S Reid; M J Barnett; A C Eaves
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-01       Impact factor: 11.205

5.  Anti-inflammatory protein TSG-6 secreted by activated MSCs attenuates zymosan-induced mouse peritonitis by decreasing TLR2/NF-κB signaling in resident macrophages.

Authors:  Hosoon Choi; Ryang Hwa Lee; Nikolay Bazhanov; Joo Youn Oh; Darwin J Prockop
Journal:  Blood       Date:  2011-05-06       Impact factor: 22.113

6.  Branchless and Hedgehog operate in a positive feedback loop to regulate the initiation of neuroblast division in the Drosophila larval brain.

Authors:  A L Barrett; S Krueger; S Datta
Journal:  Dev Biol       Date:  2008-03-04       Impact factor: 3.582

7.  Delineation of target expression profiles in CD34+/CD38- and CD34+/CD38+ stem and progenitor cells in AML and CML.

Authors:  Harald Herrmann; Irina Sadovnik; Gregor Eisenwort; Thomas Rülicke; Katharina Blatt; Susanne Herndlhofer; Michael Willmann; Gabriele Stefanzl; Sigrid Baumgartner; Georg Greiner; Axel Schulenburg; Niklas Mueller; Werner Rabitsch; Martin Bilban; Gregor Hoermann; Berthold Streubel; Daniel A Vallera; Wolfgang R Sperr; Peter Valent
Journal:  Blood Adv       Date:  2020-10-27

8.  Targeting and hematopoietic suppression of human CD34+ cells by measles virus.

Authors:  Marianne Manchester; Kent A Smith; Danelle S Eto; Hugh B Perkin; Bruce E Torbett
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

Review 9.  Evolving paradigms for repair of tissues by adult stem/progenitor cells (MSCs).

Authors:  Darwin J Prockop; Daniel J Kota; Nikolay Bazhanov; Roxanne L Reger
Journal:  J Cell Mol Med       Date:  2010-09       Impact factor: 5.310

10.  Therapeutic potential of stem cells in orthopedics.

Authors:  Chelsea Shields Bahney; Theodore Miclau
Journal:  Indian J Orthop       Date:  2012-01       Impact factor: 1.251

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.